side effects of semaglutide and tirzepatide caused roughly half as many patients to stop treatment because gastrointestinal as semaglutide. In the first major head-to-head obesity trial, GI side effects caused treatment discontinuation in: Tirzepatide Tirzepatide vs. Semaglutide: What You

This necessity limits accessibility and increases the cost, making it less feasible for continuous use

The Benoist et al

The computations and data handling were enabled by resources in projects SNIC 2022/23-445 and SNIC 2022/23-848 provided by the National Academic Infrastructure for Supercomputing in Sweden at UPPMAX, funded by the Swedish Research Council through grant agreement 2022-06725

Participants who stopped after achieving substantial weight loss experienced gradual regain over the following year

Coupling AAV-mediated promoterless gene targeting to SaCas9 nuclease to efficiently correct liver metabolic diseases

Oxidative stress: a comprehensive review of biochemical, molecular, and genetic aspects in the pathogenesis and management of varicocele